KSCM
TNGX icon

Kamunting Street Capital Management’s Tango Therapeutics TNGX Stock Holding History

Kamunting Street Capital Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-48,000
Closed -$549K – 105
2020
Q4 		$549K Sell
48,000
-36,470
-43% -$384K 0.29% 63
2020
Q3 		$875K Buy
+84,470
New +$863K 0.55% 26

Other funds holding TNGX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Kamunting Street Capital Management's TNGX Position: Q1 2021 in Review

Kamunting Street Capital Management sold out of Tango Therapeutics (TNGX) in Q1 2021, closing a stake of 48,000 shares — an estimated $549K sold.

Kamunting Street Capital Management first reported a position in TNGX in Q3 2020 and held it in 2 quarters. The position peaked at $875K in Q3 2020. 36 funds tracked by Wall St. Rank hold TNGX as of Q1 2021.

  • Kamunting Street Capital Management reported no remaining Tango Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Kamunting Street Capital Management sold 48,000 Tango Therapeutics shares in Q1 2021, an estimated $549K.
  • Kamunting Street Capital Management first reported a position in Tango Therapeutics in Q3 2020 and held it in 2 quarters.
  • Kamunting Street Capital Management's Tango Therapeutics position peaked at $875K in Q3 2020.
  • 36 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2021.

Based on Kamunting Street Capital Management's 13F filing for Q1 2021, filed 17 May 2021.